Axon’s Uptrend May Remain IntactAxon Enterprise has been climbing since last summer, and some traders may think its uptrend remains intact.
The first pattern on today’s chart is the tight consolidation pattern since February. The broader market revisited prices from a year prior, but the law-enforcement IT company never broke lev
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
4.8 EUR
364.21 M EUR
2.01 B EUR
73.55 M
About Axon Enterprise, Inc.
Sector
Industry
CEO
Patrick W. Smith
Website
Headquarters
Scottsdale
Founded
1993
FIGI
BBG01TNWVX20
Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.
AXON , LONG Meets the 6 key requirements , rotated into this at close today from NFLX .
NFLX was doing really good and even closed pretty ok all in all after being down lower but it was a lower close vs prior so I punish it , I actually also got into DUOL using other half of NFLX equity .
NFLX may recover bu
AXON & KTOS: Completely Overvalued at This Stage**📉 AXON & KTOS: Completely Overvalued at This Stage**
Both AXON and KTOS have run too far, too fast. Valuations are stretched, and the risk-reward is no longer attractive. At these levels, the upside looks limited while the downside potential is growing. I'm taking a short position against both.
703 seems as clear as day light however a few things may stand In the way of that upper movement from a technical perspective, the fundamental and catalyst side has been favoring this stock with the amount of good news that it is being given positive reviews. Therefore, I am bullish on TA because it corresponds to that PR.
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Curated watchlists where 1AXON is featured.
Related stocks
Frequently Asked Questions
The current price of 1AXON is 555.0 EUR — it has increased by 4.25% in the past 24 hours. Watch AXON ENT stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange AXON ENT stocks are traded under the ticker 1AXON.
1AXON stock has risen by 4.84% compared to the previous week, the month change is a 4.84% rise, over the last year AXON ENT has showed a 4.88% increase.
We've gathered analysts' opinions on AXON ENT future price: according to them, 1AXON price has a max estimate of 702.29 EUR and a min estimate of 513.55 EUR. Watch 1AXON chart and read a more detailed AXON ENT stock forecast: see what analysts think of AXON ENT and suggest that you do with its stocks.
1AXON reached its all-time high on May 2, 2025 with the price of 554.8 EUR, and its all-time low was 514.8 EUR and was reached on Apr 25, 2025. View more price dynamics on 1AXON chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1AXON stock is 0.04% volatile and has beta coefficient of 1.67. Track AXON ENT stock price on the chart and check out the list of the most volatile stocks — is AXON ENT there?
Yes, you can track AXON ENT financials in yearly and quarterly reports right on TradingView.
AXON ENT is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
1AXON earnings for the last quarter are 2.01 EUR per share, whereas the estimation was 1.36 EUR resulting in a 48.15% surprise. The estimated earnings for the next quarter are 1.18 EUR per share. See more details about AXON ENT earnings.
AXON ENT revenue for the last quarter amounts to 555.58 M EUR, despite the estimated figure of 546.75 M EUR. In the next quarter, revenue is expected to reach 542.02 M EUR.
1AXON net income for the last quarter is 130.58 M EUR, while the quarter before that showed 60.20 M EUR of net income which accounts for 116.93% change. Track more AXON ENT financial stats to get the full picture.
No, 1AXON doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 5, 2025, the company has 4.1 K employees. See our rating of the largest employees — is AXON ENT on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AXON ENT EBITDA is 103.56 M EUR, and current EBITDA margin is 5.36%. See more stats in AXON ENT financial statements.
Like other stocks, 1AXON shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AXON ENT stock right from TradingView charts — choose your broker and connect to your account.